Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boullanger, N.
Right arrow Articles by Michaud, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boullanger, N.
Right arrow Articles by Michaud, J. L.
(Chest. 1996;109:1400-1401.)
© 1996 American College of Chest Physicians

Atrial Myxoma Mimicking Systemic Disease

Profile Modified by Flurbiprofen Administration

Nadine Boullanger MD1; Dominique El Kouri MD1; Bernard Planchon MD1; Fanny Gaillard MD2; and Jean Luc Michaud MD3

1 From the Service de Médecine Interne, Centre Hospitalier Universitaire, Nantes, France
2 From the Service d'Anatomie Pathologique, Centre Hospitalier Universitaire, Nantes, France
3 From the Service de Chirurgie Thoracique et Cardio-Vasculaire, Centre Hospitalier Universitaire, Nantes, France

A patient had a left atrial myxoma which was modified by flurbiprofen administration. The diagnosis was made 42 months after the first symptoms appeared. Flurbiprofen may have reduced interleukin-6 secretion by the tumor, leading to a delayed diagnosis.

Key Words: interleukin-6 • myxoma • nonsteroidal anti-inflammatory drug






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Chest Physicians.